Osimertinib in EGFR-Mutated Lung Cancer: A Review of the Existing and Emerging Clinical Data - Docwire News Doc Wire News, 02 Sep 2021 This article was originally published here Onco Targets Ther. 2021 Aug 26;14:4579-4597.